mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy

mRNA therapy is a novel anticancer strategy based on in vitro transcription (IVT), which has potential for the treatment of malignant tumors. The outbreak of the COVID-19 pandemic in the early 21st century has promoted the application of mRNA technologies in SARS-CoV-2 vaccines, and there has been a great deal of interest in the research and development of mRNA cancer vaccines. There has been progress in a number of key technologies, including mRNA production strategies, delivery systems, antitumor immune strategies, etc. These technologies have accelerated the progress and clinical applications of mRNA therapy, overcoming problems encountered in the past, such as instability, inefficient delivery, and weak immunogenicity of mRNA vaccines. This review provides a detailed overview of the production, delivery systems, immunological mechanisms, and antitumor immune response strategies for mRNA cancer vaccines. We list some mRNA cancer vaccines that are candidates for cancer treatment and discuss clinical trials in the field of tumor immunotherapy. In addition, we discuss the immunological mechanism of action by which mRNA vaccines destroy tumors as well as challenges and prospects for the future.

• Publication year

  2022

• Venue

  Frontiers in Immunology

• Publication date

  2022-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fimmu.2022.887125PMID 35720301PMCID 9201022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

  2021cited by this paper
• Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

  2021cited by this paper
• Self-assembled polymeric micelle as a novel mRNA delivery carrier

  2021cited by this paper
• Dendrimer-Coated Gold Nanoparticles for Efficient Folate-Targeted mRNA Delivery In Vitro

  2021cited by this paper
• mRNA Delivery by a pH-Responsive DNA Nano-Hydrogel.

  2021cited by this paper
• mRNA therapeutics in cancer immunotherapy

  2021cited by this paper
• The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

  2021cited by this paper
• Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions.

  2021cited by this paper
• mRNA vaccine for cancer immunotherapy

  2021cited by this paper
• BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

  2021cited by this paper
• Polymeric micelles in cancer therapy: State of the art.

  2021cited by this paper
• In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy.

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• BNT162b vaccines protect rhesus macaques from SARS-CoV-2

  2021cited by this paper
• Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.

  2021cited by this paper
• The challenge and prospect of mRNA therapeutics landscape.

  2020cited by this paper
• Recent advances in mRNA vaccine technology.

  2020cited by this paper
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

  2020cited by this paper
• 391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors

  2020cited by this paper
• Public needs to prep for vaccine side effects.

  2020cited by this paper
• Co-Polymer Functionalised Gold Nanoparticles Show Efficient Mitochondrial Targeted Drug Delivery in Cervical Carcinoma Cells.

  2020cited by this paper
• Abstract CT032: A phase 1/2, open-label, multicenter, dose escalation and efficacy study of mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding human OX40L, for intratumoral injection alone or in combination with durvalumab for patients with advanced malignancies

  2020cited by this paper
• Folate-Targeted Transgenic Activity of Dendrimer Functionalized Selenium Nanoparticles In Vitro

  2020cited by this paper
• COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

  2020cited by this paper
• Recent developments of RNA-based vaccines in cancer immunotherapy

  2020cited by this paper
• Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression

  2020cited by this paper
• Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

  2020cited by this paper
• Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

  2020cited by this paper
• An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

  2020cited by this paper
• Decoding mRNA translatability and stability from the 5′ UTR

  2020cited by this paper
• Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire

  2020cited by this paper
• Functional Composites and Structures

  2019cited by this paper
• Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.

  2019cited by this paper
• Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs

  2019cited by this paper
• A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

  2019cited by this paper
• Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

  2019cited by this paper
• A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA

  2019cited by this paper
• Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.

  2019cited by this paper
• DNA Logic Operations in Living Cells Utilizing Lysosome-Recognizing Framework Nucleic Acid Nanodevices for Subcellular Imaging.

  2019cited by this paper
• Triplex DNA Nanoswitch for pH-Sensitive Release of Multiple Cancer Drugs.

  2019cited by this paper
• Study of conformational transitions of i-motif DNA using time-resolved fluorescence and multivariate analysis methods

  2019cited by this paper
• Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing

  2019influential reference
• Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

  2019cited by this paper
• Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine.

  2019cited by this paper
• Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.

  2019cited by this paper
• DNA and mRNA vaccination against allergies

  2018cited by this paper
• Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

  2018cited by this paper
• Considerations in the Use of Codon Optimization for Recombinant Protein Expression.

  2018cited by this paper
• Autophagy maintains tumor growth through circulating arginine

  2018influential reference
• Dendrimer functionalized folate-targeted gold nanoparticles for luciferase gene silencing in vitro: A proof of principle study

  2018cited by this paper
• CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

  2018cited by this paper
• MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

  2018cited by this paper
• Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification

  2018cited by this paper
• mRNA vaccines — a new era in vaccinology

  2018cited by this paper
• Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

  2018cited by this paper
• Stereoselective Stabilization of Polymeric Vitamin E Conjugate Micelles.

  2017cited by this paper
• Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

  2017cited by this paper
• Tools for translation: non-viral materials for therapeutic mRNA delivery

  2017cited by this paper
• Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery

  2017cited by this paper
• Synthetic mRNA capping

  2017cited by this paper
• Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

  2017cited by this paper
• Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem

  2017cited by this paper
• Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines

  2016cited by this paper
• Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination

  2016cited by this paper
• Vitamin E-Labeled Polyethylenimine for in vitro and in vivo Gene Delivery.

  2016cited by this paper
• Next Steps in Immuno-Oncology: Enhancing Antitumor Effects Through Appropriate Patient Selection and Rationally Designed Combination Strategies.

  2016cited by this paper
• mRNA vaccine delivery using lipid nanoparticles.

  2016cited by this paper
• Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.

  2016cited by this paper
• Next steps in immuno-oncology: enhancing antitumor effects through appropriate patient selection and rationally designed combination strategies

  2016cited by this paper
• A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2′O-Methylated Self RNA

  2015cited by this paper
• Neoantigens in cancer immunotherapy

  2015cited by this paper
• Landscape of Tumor Antigens in T Cell Immunotherapy

  2015cited by this paper
• Mutant MHC class II epitopes drive therapeutic immune responses to cancer

  2015cited by this paper
• Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

  2015cited by this paper
• Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.

  2015cited by this paper
• Exposing synonymous mutations.

  2014cited by this paper
• Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

  2014cited by this paper
• Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

  2014influential reference
• mRNA-based therapeutics — developing a new class of drugs

  2014cited by this paper
• Optimization of PAMAM-gold nanoparticle conjugation for gene therapy.

  2014cited by this paper
• DNA nanotechnology based on i-motif structures.

  2014cited by this paper
• In vitro transcription of long RNA containing modified nucleosides.

  2013cited by this paper
• The applications of Vitamin E TPGS in drug delivery.

  2013cited by this paper
• HPLC purification of in vitro transcribed long RNA.

  2013cited by this paper
• The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.

  2012cited by this paper
• Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors.

  2012cited by this paper
• A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding

  2011influential reference
• Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo.

  2010cited by this paper
• Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.

  2007cited by this paper
• High Guanine and Cytosine Content Increases mRNA Levels in Mammalian Cells

  2006cited by this paper
• Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

  2005cited by this paper
• Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA

  2005cited by this paper
• The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

  2004cited by this paper
• Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

  2004cited by this paper
• Supramolecular Assemblies of DNA Delivery Systems

  2002cited by this paper
• In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

  2000cited by this paper
• In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies

  2000cited by this paper
• RNA Melanoma Vaccine: Induction of Antitumor Immunity by Human Glycoprotein 100 mRNA Immunization

  1999cited by this paper
• In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

  1998cited by this paper
• State of the Art

  1997cited by this paper

• Fimbriae potentiate Aggregatibacter actinomycetemcomitans for periodontal disease

  2026cites this paper
• Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization

  2025cites this paper
• Novel therapeutic approaches to cancer immunotherapy and mRNA vaccines technology: a review

  2025cites this paper
• Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific and Neo-antigens in Follicular Cell-derived Thyroid Cancers.

  2025cites this paper
• Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery.

  2025cites this paper
• Patent analysis of mRNA therapy using deep learning.

  2025cites this paper
• mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)—A Promising Avenue in Cancer Immunotherapy

  2025cites this paper
• Antimicrobial peptide hydrogels: synthesis, ROS regulation mechanism, and multimodal therapeutic applications in drug delivery systems.

  2025cites this paper
• Immune-based cancer therapies: mechanistic insights, clinical progress, and future directions

  2025cites this paper
• Precision Targeting of Myeloid Cells via Peptide Dendrimer‐Lipid Nanocarriers: A Novel Platform for Potent Cancer Immunotherapies

  2025cites this paper
• mRNA-encoded mutant HPV16/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice

  2025cites this paper
• Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer

  2025cites this paper
• mRNA vaccines for gastrointestinal cancers: a paradigm shift in treatment

  2025cites this paper
• Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases.

  2025cites this paper
• mRNA-based cancer vaccines: A novel approach to melanoma treatment.

  2025cites this paper
• Nanovaccines: Antigen selection, stabilization, adjuvantation, formulation, and evaluation

  2025cites this paper
• Unlocking mRNA Vaccine Potential in Liver Cancer Treatment via Synergistic Bile Acid Modulation

  2025cites this paper
• Advances in mRNA vaccine therapy for breast cancer research

  2025cites this paper
• Cancer mRNA vaccines: clinical application progress and challenges.

  2025cites this paper
• The therapeutic effect of mRNA vaccines in glioma: a comprehensive review

  2025cites this paper
• Nanocarriers for cutting-edge cancer immunotherapies

  2025cites this paper
• The advent of clinical self-amplifying RNA vaccines.

  2025cites this paper
• Prostate Cancer Vaccines: Progress, Challenges, and Future Directions

  2025cites this paper
• Improving the Efficacy of Cancer mRNA Vaccines

  2025cites this paper
• Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs

  2025cites this paper
• Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy

  2025cites this paper
• CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity

  2025cites this paper
• Advancement insights in cancer vaccines: mechanisms, types, and clinical applications

  2025cites this paper
• mRNA vaccines in the context of cancer treatment: from concept to application

  2025cites this paper
• Inflammation-driven Oncogenesis: Precision Medicine and Immunotherapeutic Strategies.

  2025cites this paper
• Bioinformatics analysis reveals novel tumor antigens and immune subtypes of skin cutaneous melanoma contributing to mRNA vaccine development

  2025cites this paper
• On-patient medical record and mRNA therapeutics using intradermal microneedles

  2025cites this paper
• Ionizable Lipids with Branched Linkers Enhance the Delivery of mRNA Vaccines.

  2025cites this paper
• Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy

  2025cites this paper
• Overview of Types of Vaccines and Vaccination Methods

  2025cites this paper
• Antitumor mRNA vaccines based on neoantigens

  2025cites this paper
• Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID‐19

  2024cites this paper
• Path towards mRNA delivery for cancer immunotherapy from bench to bedside

  2024cites this paper
• Ionizable Polymeric Micelles with Phenylalanine Moieties Enhance Intracellular Delivery of Self-Replicating RNA for Long-Lasting Protein Expression In Vivo.

  2024cites this paper
• Breaking Barriers: A Future Perspective on Glioblastoma Therapy with mRNA-Based Immunotherapies and Oncolytic Viruses

  2024cites this paper
• RETRACTED ARTICLE: Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact

  2024cites this paper
• Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.

  2024cites this paper
• Lipid Nanoparticle-Based Delivery System—A Competing Place for mRNA Vaccines

  2024cites this paper
• Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside

  2024cites this paper
• mRNA vaccines in gastric cancer: How close are we?

  2024cites this paper
• Effective synthesis of circRNA via a thermostable T7 RNA polymerase variant as the catalyst

  2024cites this paper
• Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances.

  2024cites this paper
• Nanodrug Delivery Systems in Antitumor Immunotherapy

  2024cites this paper
• Alginate-Chitosan Biodegradable and Biocompatible Based Hydrogel for Breast Cancer Immunotherapy and Diagnosis: A Comprehensive Review

  2024cites this paper
• Effective Synthesis of High-Integrity mRNA Using In Vitro Transcription

  2024cites this paper
• Standing the test of COVID-19: charting the new frontiers of medicine

  2024cites this paper
• Tumor Microenvironment‐Responsive Polymer‐Based RNA Delivery Systems for Cancer Treatment

  2024cites this paper
• Targeting Pediatric Solid Tumors in the New Era of RNA Therapeutics.

  2024cites this paper
• The Multifaceted Role of Tissue-Resident Memory T Cells.

  2024cites this paper
• Exosome for mRNA delivery: strategies and therapeutic applications

  2024cites this paper
• Immunotherapy in mastitis: state of knowledge, research gaps and way forward

  2024cites this paper
• Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA

  2024cites this paper
• mRNA vaccine development and applications: A special focus on tumors (Review)

  2024cites this paper
• Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology

  2024cites this paper
• Current mRNA-Based Vaccine Strategies for Glioma Treatment.

  2024cites this paper
• Low-Dose Mildronate-Derived Lipidoids for Efficient mRNA Vaccine Delivery with Minimal Inflammation Side Effects.

  2024cites this paper
• Reaching Outer Space and Enabling the mRNA Revolution: A Critical Role of Partnerships for Successful Drug and Vaccine Development.

  2024cites this paper
• Recent progress in cancer vaccines and nanovaccines.

  2024cites this paper
• Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced

  2024cites this paper
• Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

  2024cites this paper
• mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy

  2024cites this paper
• mRNA—From COVID-19 Treatment to Cancer Immunotherapy

  2023cites this paper
• mRNA‐HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV‐mediated cancers via subcutaneous immunization

  2023cites this paper
• Nanovaccines: An effective therapeutic approach for cancer therapy.

  2023cites this paper
• Intradermal Delivery of Naked mRNA Vaccines via Iontophoresis

  2023cites this paper
• mRNA vaccines in gastric cancer: How close are we?

  2023cites this paper
• mRNA Epi-Drugs: The Possible Use and Potential of mRNA in Radiation Therapy.

  2023cites this paper
• Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.

  2023cites this paper
• Neoantigens: promising targets for cancer therapy

  2023cites this paper
• mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice

  2023cites this paper
• Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines

  2023cites this paper
• In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future

  2023cites this paper
• Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing

  2023cites this paper
• Effect of the COVID-19 pandemic on the pediatric infectious disease landscape

  2023cites this paper
• Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

  2023influential citation
• Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy

  2023cites this paper
• Emergence of mRNA vaccines in the management of cancer

  2023influential citation
• Hyperbranched Polymer-Based Vaccines for Cancer Immunotherapy.

  2023cites this paper
• Unlocking Delivery Strategies for mRNA Therapeutics.

  2023cites this paper
• Avances en el desarrollo de nuevas vacunas contra Fasciola hepatica

  2023cites this paper
• Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2

  2023cites this paper
• Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)

  2023cites this paper
• Emergence of Nanoscale Drug Carriers through Supramolecular Self-Assembly of RNA with Calixarene

  2023cites this paper
• A View on Drug Development for Cancer Prevention.

  2023cites this paper
• Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies.

  2023cites this paper
• Therapeutic Cancer Vaccines and Their Future Implications

  2023cites this paper
• The Race of mRNA therapy: Evidence from Patent Landscape (preprint)

  2023cites this paper
• Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities

  2023cites this paper
• Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

  2023cites this paper
• Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development

  2022cites this paper
• Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation

  2022cites this paper
• Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients.

  2022cites this paper
• mRNA vaccines for cancer immunotherapy

  2022cites this paper
• Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines

  2022cites this paper
• MRI reporter genes in the era of gene transfer

  2022cites this paper